Mostrar el registro sencillo del ítem

dc.contributor.author
Ugalde Arbizu, Maider  
dc.contributor.author
Aguilera Correa, John Jairo  
dc.contributor.author
García Almodóvar, Victoria  
dc.contributor.author
Ovejero Paredes, Karina  
dc.contributor.author
Díaz García, Diana  
dc.contributor.author
Esteban, Jaime  
dc.contributor.author
Páez, Paulina Laura  
dc.contributor.author
Prashar, Sanjiv  
dc.contributor.author
San Sebastian, Eider  
dc.contributor.author
Filice, Marco  
dc.contributor.author
Gómez Ruiz, Santiago  
dc.date.available
2024-02-14T11:53:35Z  
dc.date.issued
2023-02  
dc.identifier.citation
Ugalde Arbizu, Maider; Aguilera Correa, John Jairo; García Almodóvar, Victoria; Ovejero Paredes, Karina; Díaz García, Diana; et al.; Dual Anticancer and Antibacterial Properties of Silica-Based Theranostic Nanomaterials Functionalized with Coumarin343, Folic Acid and a Cytotoxic Organotin(IV) Metallodrug; MDPI; Pharmaceutics; 15; 2; 2-2023; 1-22  
dc.identifier.issn
1999-4923  
dc.identifier.uri
http://hdl.handle.net/11336/226762  
dc.description.abstract
Five different silica nanoparticles functionalized with vitamin B12, a derivative of coumarin found in green plants and a minimum content of an organotin(IV) fragment (1-MSN-Sn, 2-MSN-Sn, 2-SBA-Sn, 2-FSPm-Sn and 2-FSPs-Sn), were identified as excellent anticancer agents against triple negative breast cancer, one of the most diagnosed and aggressive cancerous tumors, with very poor prognosis. Notably, compound 2-MSN-Sn shows selectivity for cancer cells and excellent luminescent properties detectable by imaging techniques once internalized. The same compound is also able to interact with and nearly eradicate biofilms of Staphylococcus aureus, the most common bacteria isolated from chronic wounds and burns, whose treatment is a clinical challenge. 2-MSN-Sn is efficiently internalized by bacteria in a biofilm state and destroys the latter through reactive oxygen species (ROS) generation. Its internalization by bacteria was also efficiently monitored by fluorescence imaging. Since silica nanoparticles are particularly suitable for oral or topical administration, and considering both its anticancer and antibacterial activity, 2-MSN-Sn represents a new dual-condition theranostic agent, based primarily on natural products or their derivatives and with only a minimum amount of a novel metallodrug.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
MDPI  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by/2.5/ar/  
dc.subject
BACTERIA  
dc.subject
BIOFILM  
dc.subject
BIOFILM  
dc.subject
CANCER  
dc.subject
LUMINESCENCE  
dc.subject
ORAL  
dc.subject
S. AUREUS  
dc.subject
THERANOSIS  
dc.subject
TOPICAL  
dc.subject
WOUND HEALING  
dc.subject.classification
Enfermedades Infecciosas  
dc.subject.classification
Ciencias de la Salud  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Dual Anticancer and Antibacterial Properties of Silica-Based Theranostic Nanomaterials Functionalized with Coumarin343, Folic Acid and a Cytotoxic Organotin(IV) Metallodrug  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2024-02-09T11:18:53Z  
dc.journal.volume
15  
dc.journal.number
2  
dc.journal.pagination
1-22  
dc.journal.pais
Suiza  
dc.description.fil
Fil: Ugalde Arbizu, Maider. Universidad del País Vasco; España  
dc.description.fil
Fil: Aguilera Correa, John Jairo. Universidad Autónoma de Madrid; España  
dc.description.fil
Fil: García Almodóvar, Victoria. Universidad Rey Juan Carlos; España  
dc.description.fil
Fil: Ovejero Paredes, Karina. Universidad Complutense de Madrid; España  
dc.description.fil
Fil: Díaz García, Diana. Universidad Rey Juan Carlos; España  
dc.description.fil
Fil: Esteban, Jaime. Universidad Rey Juan Carlos; España  
dc.description.fil
Fil: Páez, Paulina Laura. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica; Argentina  
dc.description.fil
Fil: Prashar, Sanjiv. Universidad Rey Juan Carlos; España  
dc.description.fil
Fil: San Sebastian, Eider. Universidad del País Vasco; España  
dc.description.fil
Fil: Filice, Marco. Universidad Complutense de Madrid; España  
dc.description.fil
Fil: Gómez Ruiz, Santiago. Universidad Rey Juan Carlos; España  
dc.journal.title
Pharmaceutics  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.mdpi.com/1999-4923/15/2/560  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.3390/pharmaceutics15020560